Summit Financial Strategies’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.1M Sell
1,755
-45
-3% -$46K 0.15% 51
2026
Q1
$1.66M Sell
1,800
-20
-1% -$20.3K 0.13% 54
2025
Q4
$1.96M Sell
1,820
-110
-6% -$105K 0.16% 49
2025
Q3
$1.47M Buy
1,930
+2
+0.1% +$1.49K 0.13% 53
2025
Q2
$1.5M Sell
1,928
-10
-0.5% -$7.77K 0.14% 50
2025
Q1
$1.6M Sell
1,938
-111
-5% -$92.4K 0.16% 46
2024
Q4
$1.58M Sell
2,049
-56
-3% -$46.4K 0.17% 48
2024
Q3
$1.86M Buy
2,105
+11
+0.5% +$9.89K 0.21% 39
2024
Q2
$1.9M Sell
2,094
-24
-1% -$19.2K 0.24% 37
2024
Q1
$1.65M Sell
2,118
-33
-2% -$23.5K 0.23% 37
2023
Q4
$1.25M Buy
2,151
+39
+2% +$22.8K 0.19% 39
2023
Q3
$1.13M Buy
2,112
+700
+50% +$361K 0.22% 35
2023
Q2
$662K Sell
1,412
-348
-20% -$146K 0.12% 59
2023
Q1
$604K Buy
1,760
+328
+23% +$111K 0.12% 61
2022
Q4
$524K Sell
1,432
-100
-7% -$35.5K 0.11% 63
2022
Q3
$496K Sell
1,532
-43
-3% -$13.6K 0.12% 59
2022
Q2
$511K Buy
1,575
+337
+27% +$101K 0.12% 62
2022
Q1
$355K Sell
1,238
-108
-8% -$27.8K 0.07% 79
2021
Q4
$372K Hold
1,346
0.07% 77
2021
Q3
$311K Sell
1,346
-15
-1% -$3.7K 0.06% 90
2021
Q2
$312K Buy
+1,361
New +$273K 0.06% 88

Other funds holding LLY

Summit Financial Strategies's LLY Position: Q2 2026 in Review

Summit Financial Strategies reduced its Eli Lilly (LLY) stake by 2.5% in Q2 2026, selling an estimated $46K and leaving 1,755 shares worth $2.1M. The position accounts for 0.15% of the portfolio, ranked #51.

Summit Financial Strategies first reported a position in LLY in Q2 2021 and has held it in 21 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Summit Financial Strategies held 1,755 shares of Eli Lilly worth $2.1M as of Q2 2026.
  • Summit Financial Strategies sold 45 Eli Lilly shares in Q2 2026, an estimated $46K.
  • Eli Lilly made up 0.15% of Summit Financial Strategies's portfolio in Q2 2026, its #51 holding.
  • Summit Financial Strategies first reported a position in Eli Lilly in Q2 2021 and has held it in 21 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Summit Financial Strategies's 13F filing for Q2 2026, filed 24 Jul 2026.